Related Experiment Video
Updated: Jun 3, 2025
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
Medication adherence feedback with older adults with cognitive impairment: A mixed methods study
Kelli L Sullivan1,2, Emily S Hallowell2,3, Allyson Goldstein1,4
1Department of Psychiatry, Brown University Health, Providence, RI, USA.
The Clinical Neuropsychologist
|January 10, 2025
Summary
Providing medication adherence feedback to older adults with cognitive impairment is feasible and impactful. Awareness of medication errors motivates behavior change, improving medication self-management.
Area of Science:
- Gerontology
- Neuroscience
- Pharmacology
Background:
- Older adults with cognitive impairment face challenges with medication adherence.
- Medication-taking errors pose significant health risks for this population.
Purpose of the Study:
- To assess the impact of medication adherence feedback on older adults with cognitive impairment.
- To explore participant reactions and self-reported behavior changes following feedback.
Main Methods:
- Electronic monitoring of medication adherence over 8 weeks in 40 participants with mild cognitive impairment or dementia.
- Provision of verbal and visual adherence feedback, with initial reactions assessed via Motivational Interviewing.
- Quantitative and thematic analyses of adherence data, participant reactions, and self-management changes.
Main Results:
- Electronic monitoring revealed 20% suboptimal adherence, contrasting with high self-rated adherence.
- 53% of participants were surprised by their adherence results; 45% reported initial motivation to change.
- Participants surprised by errors showed greater motivation; 50% reported making changes post-study.
Conclusions:
- Medication adherence monitoring with feedback is a feasible and impactful intervention for older adults with cognitive impairment.
- Increased awareness of medication errors is a key driver for improved medication self-management.
- The study demonstrated participant-reported behavior change following adherence feedback.
Keywords:
Cognitive impairmentMedication Event Monitoring Systemscompensatory strategieseveryday functioningmedication adherencemotivational interviewingMore Related Videos
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.3K
11:21Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
8.2K
Related Concept Videos
01:28Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
01:30Cognitive Development During Adulthood
50
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
50
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:22Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95